Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey

Fig. 1

Seroprevalence of Zika virus (ZIKV) antibodies in Central Vietnam, 2017–2018. The seroprevalence of Zika virus antibodies according to (a) age and (b) ethnicity. A total of 83 participants (83/801, 10.3%) demonstrated anti-ZIKV IgM antibodies as determined by using enzyme-linked immunosorbent assays. ZIKV neutralizing antibodies was determined by using plaque-reduction neutralization test (PRNT) and for confirming infection to ZIKV. Prevalence rates (anti-DENV IgG antibodies and anti-ZIKV NS1 IgG antibodies) was determined by using a total of 83 samples and 88 samples, respectively

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us